Related Experiment Video
Updated: May 17, 2026
08:18
Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
Published on: July 27, 2022
Pharmacy practice in Qatar: challenges and opportunities.
1College of Pharmacy, Qatar University, Doha, Qatar.
Southern Med Review
|October 25, 2012
Summary
Qatar
Area of Science:
- Pharmaceutical practice and healthcare development in Qatar.
- Pharmacy profession challenges and advancements in the Middle East.
- National health strategies and educational initiatives in pharmacy.
Background:
- Qatar, a rapidly developing Gulf nation, is enhancing its healthcare services, including pharmaceuticals.
- The pharmacy profession in Qatar lacks an autonomous regulatory body, facing challenges common to the Middle East.
- Despite challenges, Qatar is actively developing its pharmaceutical sector.
Purpose of the Study:
- To provide an overview of the pharmaceutical landscape in Qatar.
- To discuss the challenges confronting pharmacy practice in Qatar.
- To highlight key initiatives driving pharmacy forward in Qatar.
Main Methods:
- Commentary on the current state of pharmacy in Qatar.
- Analysis of challenges and developmental initiatives.
- Review of educational and leadership advancements.
Main Results:
- The pharmacy sector in Qatar is rapidly evolving.
- Key initiatives include educational reforms and leadership development.
- Alignment between practice and education is crucial for progress.
Conclusions:
- Qatar's pharmacy practice is advancing rapidly through strategic initiatives.
- Addressing challenges requires continued focus on education and leadership.
- The development of pharmacy in Qatar serves as a model for the region.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:14Drug Dissolution: Requirements and Profile Comparison
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...